Skip to content

#LSD

14 SepMon
22 AugSat
12 AugWed
22 JunMon
  1. STAT: psychedelics83

    Definium says LSD therapy DT120 helped major depression in first Phase 3 trial

    Definium Therapeutics said on Monday that its LSD therapy DT120 significantly helped patients with major depression in its first Phase 3 trial. Six weeks after a single dose.

    Why it matters: The topline gives the first Phase 3 readout for an LSD-based depression treatment, so the size of the placebo gap and the waning at 12 weeks are the numbers that will shape the next regulatory step.